Personen
Webseiten-Inhalte
Poster prizes for young scientists from MedUni Vienna's Department of Pathology
... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13&cHash=c11ba5a9f16b8fe5cd5992c14873529f
Poster prizes for young scientists from MedUni Vienna's Department of Pathology
... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4&cHash=50c6b30448d17c45db3b793d85277a70
Poster prizes for young scientists from MedUni Vienna's Department of Pathology
... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/people-of-the-meduni-vienna/?L=3
Poster prizes for young scientists from MedUni Vienna's Department of Pathology
... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/?L=3
Jan Pencik wins Nature Poster Prize
... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Twitter...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?L=3
Jan Pencik wins Nature Poster Prize
... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Twitter...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/people-of-the-meduni-vienna/?L=3
Jan Pencik wins Nature Poster Prize
... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?cHash=c392327d1d79480b30b6774d9fb3de0a&tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13
Jan Pencik wins Nature Poster Prize
... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=13&cHash=c392327d1d79480b30b6774d9fb3de0a
Jan Pencik wins Nature Poster Prize
... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=4&cHash=3a363d7eb3f191914179755d163f94fa
News
... Kenner vom Klinischen Institut für Pathologie der MedUni Wien. Die Wissenschafter nehmen an, dass bei der üblichen Chemotherapie zwar die Krebszellen, die sich im Körper ausbreiten, getötet werden, jedoch nicht die originalen "Krebsstammzellen", von denen der Tumor ursprünglich ausgeht. Lukas Kenner...
https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=3219&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=3b4d0528c57007cdb6cdc9967ba6eea2